Scripps Research Translational Institute has partnered with snaploT, a fast growing Platform as a Service for mobile-connected self-service solutions for digital and mobile clinical trials, to enable the POWERMOM clinical trial. This study launched in late spring and is enrolling pregnant women across the United States. The study aims to improve general understanding of the factors associated with a healthy pregnancy.
Most clinical trials exclude expectant mothers. Consequently, other patient populations continue to evolve while expectant mothers are consistently under-served. This study aims to change that.
POWERMOM is a research app that collects self-reported survey data and sensor data to give pregnancy researchers an inside look into the life of pregnant women when they are not in their obstetrician’s office. The snapClinical platform is the technology stack that is the driving force behind POWERMOM’s connected mHealth study. snaploT worked with Scripps Research Translational Institute to develop and implement a native app for android, iOS, and a web-based version for other devices.
Maternal health data from the study participants is collected directly from the app along with biometric data from wearables, such as activity trackers and smartwatches and sent securely to the snapClinical platform where clinicians can monitor results in real-time. The study is currently tracking measurements of an expectant mother’s physical activity, heart rate, sleeping patterns, and blood pressure.
Lead Research/Investigator Comment
Jennifer Radlin, PhD, an epidemiologist and digital medicine expert at Scripps Research who is leading the project stated, “We are currently incorporating various sensors into the study, which will allow us to collect frequent and more detailed health data from each participant.”
Founded in 2007, with the mission to individualize healthcare by leveraging the remarkable progress being made in human genomics and combining it with the power of wireless digital technologies. They recognize that every patient is unique, and their individualized healthcare tailors medical care to the patient, considering not only a person’s genes, but also their environment, behavior, and lifestyle. Bringing together basic scientists, clinical investigators, the Translational Institute fosters highly collaborative, multidisciplinary research with the greatest potential to transform the practice of healthcare and improve human health.
Based in San Diego, California, and with offices in Europe, snapIoT is the fastest-growing “Platform as a Service” provider of mobile-connected self-service platform solutions for clinical trials. SnapIoT’s senior leadership comes from the chipset division of Qualcomm, where they specialized in Core Embedded IP/LTE Multimedia Systems. They have delivered projects across many patient populations around the globe. Building on this experience, snapIoT has designed and implemented self-service mClinical IoT solutions for CROs and pharmaceutical companies. For more information and to request a free user experience, visit http://www.snapiot.com.Source: ACCESSWIRE